Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: multiple sclerosis,treatment of (Click to remove) Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999 NEJM 340:945-953, , 1999 Multiple Sclerosis NEJM 378:169-180, Reich, D.S.,et al, 2018 B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis NEJM 358:676-688, Hauser,S.L.,et al, 2008 Multiple Sclerosis Lancet 372:1502-1517, Compston,A. &Coles,A., 2008 Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis Brain 126:433-437, Filippi,M.,et al, 2003 High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003 Multiple Sclerosis Lancet 359:1221-1231, Compston,A. &Coles,A., 2002 Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS Neurol 59:636-639, Pollmann,W.,et al, 2002 Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management The Neurologist 8:227-236, Frohman,E.,et al, 2002 Multiple Sclerosis NEJM 343:938-952, Noseworthy,J.H. et al, 2000 Multiple Sclerosis, (Second of Two Parts) NEJM 307:1246-1251, McFarlin,D.E.,et al, 1982 Intrathecal Interferon in Multiple Sclerosis Arch Neurol 39:609-615, Jacobs,L.,et al, 1982 Intraspinal Steroid Therapy Neurol 31:168-171, Bernat,J.L., 1981 Showing articles 0 to 13 of 13